EYS and triple-A syndrome: In the AAA-recipient subgroup, EYS expression was also associated with shorter OS (HR 2.718; p = 0.002), DSS (HR 2.718; p = 0.002), and recurrence-free survival (RFS) (HR 2.848; p = 0.016) (Table S1).